Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.82 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.82 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.82 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 6/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.70 |
| ▸ | POLB | P06746 | 4/20 | 0.70 |
| ▸ | RECQL | P46063 | 2/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.63 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.63 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.61 |
| ▸ | LCK | P06239 | 1/20 | 0.60 |
| ▸ | IP6K2 | Q9UHH9 | 2/20 | 0.60 |
| ▸ | KDM1A | O60341 | 1/20 | 0.60 |
| ▸ | XDH | P47989 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tricin SCHEMBL44475 | 0.90 | MAOA (1.00) | MAOAAKR1B1MAPK8POLHMAPT | |
| Tricin SCHEMBL29712335 | 0.90 | MAOA (1.00) | MAOAAKR1B1MAPK8POLHMAPT | |
| SCHEMBL16894650 | 0.90 | ABCB1 (0.76) | MAOAAKR1B1MAPK8POLHMAPT | |
| Tricin SCHEMBL10809395 | 0.89 | MAOA (0.97) | MAOAAKR1B1MAPK8POLHMAPT | |
| SCHEMBL7752988 | 0.89 | MAOA (0.70) | MAOAAKR1B1MAPK8POLHMAPT | |
| SCHEMBL1676018 | 0.89 | ABCB1 (0.78) | MAOAAKR1B1MAPK8POLHMAPT | |
| SCHEMBL12378833 | 0.86 | MAOA (0.92) | MAOAAKR1B1MAPK8POLHMAPT | |
| SCHEMBL29576775 | 0.86 | MAOA (0.92) | MAOAAKR1B1MAPK8POLHMAPT | |
| SCHEMBL2485835 | 0.86 | CYP1B1 (0.83) | MAOAAKR1B1MAPK8POLHMAPT | |
| SCHEMBL2874033 | 0.86 | POLH (0.79) | MAOAAKR1B1MAPK8POLHMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530426-B2 | Topical use of a UGT inducer-containing composition comprising a dermatologically acceptable carrier to protect and/or enhance the state of the skin/hair and prevent and/or treat imperfections of the skin; flavanoids such as chrysin stimulates isoforms; protective coatings aging/ wrinkling resistance | SEDERMA SAS (FR) | 2013-09-10 | — | — | US | claimed |
| US-10953237-B2 | Methods of providing skin care using phototherapy | INDERM (FR) | 2021-03-23 | — | — | US | disclosed |
| EP-3271012-B1 | DEVICES FOR PROVIDING SKIN CARE USING PHOTOTHERAPY | INDERM (FR) | 2019-06-19 | — | — | EP | disclosed |
| US-20180071547-A1 | Methods of Providing Skin Care Using Phototherapy | INDERM (FR) | 2018-03-15 | — | — | US | disclosed |
| EP-3271012-A1 | METHODS OF PROVIDING SKIN CARE USING PHOTOTHERAPY | Inderm (FR) | 2018-01-24 | — | — | EP | disclosed |
| EP-1776161-B1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | SEDERMA S A S (FR) | 2016-10-26 | — | — | EP | disclosed |
| WO-2016146778-A1 | METHODS OF PROVIDING SKIN CARE USING PHOTOTHERAPY | INDERM (FR) | 2016-09-22 | — | — | WO | disclosed |
| US-8530426-B2 | Topical use of a UGT inducer-containing composition comprising a dermatologically acceptable carrier to protect and/or enhance the state of the skin/hair and prevent and/or treat imperfections of the skin; flavanoids such as chrysin stimulates isoforms; protective coatings aging/ wrinkling resistance | SEDERMA SAS (FR) | 2013-09-10 | — | — | US | disclosed |
| US-20080213198-A1 | Cosmetic or Dermopharmaceutical Composition Comprising at Least one Udp Glucuronosyl Transferase (Ugt) Enzymes Inducer | SEDERMA SAS (FR) | 2008-09-04 | — | — | US | disclosed |
| EP-1776161-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | Sederma S.A.S. (FR) | 2007-04-25 | — | — | EP | disclosed |
| WO-2005102266-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | SEDERMA, SAS (FR) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213198-A1 | Cosmetic or Dermopharmaceutical Composition Comprising at Least one Udp Glucuronosyl Transferase (Ugt) Enzymes Inducer | UGT1A1, UGT1A3, UGDH | MAOA 83/4885AKR1B1 246/4885MAPK8 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.